Beyond Air Inc

Stock Chart, Company Information, and Scan Results

$0.50(as of Apr 29, 3:49 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Beyond Air Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$0.50
Ticker SymbolXAIR
ExchangeNasdaq
SectorHealthcare
IndustryMedical Devices
Employees61
CountyUSA
Market Cap$5.1M
EBIDTA-25.8M
10-Day Moving Average0.51
P/E Ratio-0.14
20-Day Moving Average0.61
Forward P/E Ratio0.00
50-Day Moving Average0.76
Earnings per Share-4.47
200-Day Moving Average1.64
Profit Margin-334.37%
RSI36.56
Shares Outstanding10.5M
ATR0.07
52-Week High5.84
Volume194,390
52-Week Low0.43
Most Recent Support Level0.48
Book Value8.3M
Most Recent Resistance Level0.55
P/B Ratio0.53
Upper Keltner0.77
P/S Ratio0.63
Lower Keltner0.46
Debt-to-Equity Ratio0.77
Next Earnings DateUnknown
Cash Surplus7.8M
Next Ex-Dividend DateUnknown

Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through three segments: Beyond Air, Beyond Cancer, and NeuroNos. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM) at home. In addition, the company develops ultra-high concentration (UNO) that is in Phase 1 clinical trial to treat multiple solid and cutaneous tumors; and selective neuronal nitric oxide synthase (nNOS) inhibitor for the treatment of neurological conditions and autism spectrum disorder. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.

Beyond Air Inc In Our Stock Scanner

As of Apr 29, 2026
example chart graphic
Scan Name: Discounted Stocks with Earnings GrowthScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Undervalued StocksScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Bullish Harami PatternScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low PS RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.